Drug or treatment
Galcanezumab clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Galcanezumab that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Galcanezumab for amyloid-confirmed mild-to-moderate Alzheimer's disease
This trial will try injectable Galcanezumab in people aged 50–90 with amyloid-confirmed mild-to-moderate Alzheimer's disease to see if it improves symptoms or slows decline.
-
Evaluating Emgality's effects on breastfeeding mothers with migraines
This study is testing how a migraine medication called Emgality affects breast milk in nursing mothers and how it impacts their health and their babies' growth over the first year.
Quick answers
How many clinical trials of Galcanezumab are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.